Overview

Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to try to see if antidepressant medications cause changes in QEEG measurements in the brain. QEEG is a mathematical analysis of electrical currents in the brain using electrodes placed on the scalp. Previous studies have shown that mood improvement (clinical response) caused by antidepressant medications was preceded by changes in QEEG measurements in the brain.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Medtronic - MITG
Treatments:
Citalopram
Fluoxetine
Fluvoxamine
Paroxetine
Serotonin
Serotonin Uptake Inhibitors
Sertraline
Venlafaxine Hydrochloride